MTOR and neoplasm: Due to the oncogenic roles of mTORC1 signaling, its inhibitors, such as rapamycin and sirolimus, have been applied in the clinical treatment of various tumor types.[26] Dactolisib, also called BEZ235, is a dual PI3K‐mTOR inhibitor.